Scientists at Stanford Medicine have discovered a naturally occurring molecule, BRP, which aids in weight loss while avoiding the side effects associated with drugs like Ozempic. This molecule targets ...

Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and ...

Ozempic and similar GLP-1 weight-loss medications are designed to be a lifelong treatment. But a new study finds the majority ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...

You know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid ...

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy ... The company said a Phase 3 trial showed that after 68 weeks, those who took CagriSema achieved ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The pharmaceutical industry is not stopping there. There are already 100 new drug candidates in trials, all vying for a slice ...